First biosimilar monoclonal antibody approved in Europe

"approved" green key on keyboard
The Generic Medicines Industry Association has welcomed the announcement from member company, Hospira, that its biosimilar infliximab (Inflectra) is now available in more major European markets, including Austria, Denmark, France, Germany, Greece, Italy, Luxembourg, Netherlands, Spain and Sweden. Inflectra is the first biosimilar monoclonal antibody to be approved in Europe. It provides a more affordable

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Prof services should go under MBS, not 6CPA: CHF
Next QUM, primary care, compliance key issues: NPS MedicineWise